NCT07455058Recruiting
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Francis Medical Inc.
Start Date
6/5/2026
Completion Date
7/31/2041
Summary
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Eligibility Criteria
Age Range: No minimum to No maximum
Inclusion Criteria:
* Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
* Participant is willing and able to provide written informed consent.
Exclusion Criteria:
* Contraindications per the Vanquish IFU
* Previously participated in VAPOR 2 study and is not planning to receive further Vanquish therapy.
Interventions
DEVICE
Vanquish Therapy
Conditions
Prostate Cancer
Locations
The Urology Place, Inc.
San Antonio, Texas 78240
United States
Urology of Virginia
Virginia Beach, Virginia 23462
United States